Â鶹ֱ²¥
Â鶹ֱ²¥ & Lardner LLP represented Mevo, Brazil’s leading e-prescription healthtech, in their $18 million funding round led by Prosus. Additional investors included Matrix, Jefferson River, and Floating Point.
Mevo addresses a major gap in Brazil’s health care system, where more than 150 million people manage roughly one billion handwritten prescriptions each year, creating inefficiencies that limit the development of more integrated patient services. Today, Mevo continues to modernize this landscape. Its growth strategy is built on three pillars: core e-prescription service for both large-scale health care institutions and individual practitioners; Mevo Shop, a patient-facing portal for exam scheduling and online pharmacy orders; and a dedicated vertical for pharmaceutical industry partners.
The investment will accelerate Mevo’s mission to use the e-prescription as the strategic entry point to a more connected patient journey, streamlining steps such as exam scheduling, integration with patient support programs, and seamless online medication fulfillment.
The Â鶹ֱ²¥ team was led by partner André Thiollier and included associates Trevor Mullin and Bella Tappin.
